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MacroH2A histones are variants of canonical histone H2A that are conserved among vertebrates. Previous studies have implicated
macroH2As in epigenetic gene-silencing events including X chromosome inactivation. Here we show that macroH2A is present in
developing and mature mouse oocytes. MacroH2A is localized to chromatin of germinal vesicles (GV) in both late growth stage (lg-GV) and
fully grown (fg-GV) stage oocytes. In addition, macroH2A is associated with the chromosomes of mature oocytes, and abundant macroH2A
is present in the first polar body. However, maternal macroH2A is lost from zygotes generated by normal fertilization by the late 2 pronuclei
(2PN) stage. Normal embryos at 2-, 4-, and 8-cell stages lack macroH2A except in residual polar bodies. MacroH2A protein expression
reappears in embryos after the 8-cell stage and persists in morulae and blastocysts, where nuclear macroH2A is present in both the
trophectodermal and inner cell mass cells. We followed the loss of macroH2A from pronuclei in parthenogenetic embryos generated by
oocyte activation. Abundant macroH2A is present upon the metaphase II plate and persists through parthenogenetic anaphase, but macroH2A
is progressively lost during pronuclear decondensation prior to synkaryogamy. Examination of embryos generated by intracytoplasmic sperm
injection (ICSI) revealed that macroH2A is associated exclusively with female pronuclei prior to loss in late pronucleus stage embryos. These
results outline a surprising finding that a maternal store of macroH2A is removed from the maternal genome prior to synkaryogamy, resulting
in embryos that execute three to four mitotic divisions in the absence of macroH2A prior to the onset of embryonic macroH2A expression.
D 2004 Elsevier Inc. All rights reserved.
Keywords: MacroH2A; Histone; Oocyte; Germinal vesicle; Epigenetic; Preimplantation; ParthenogenesisIntroduction
Gametogenesis yields haploid eggs or sperm whose
DNA is packaged within specialized chromatin that differs
markedly between the sexes. Shortly after fertilization,
maternal and paternal genomes and their associated chro-
matin commence a series of broad and rapid reorganizations
during the ensuing period of preimplantation development.0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.11.032
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E-mail address: theodore.rasmussen@uconn.edu (T.P. Rasmussen).These chromatin dynamics are of special interest because
chromatin is the principle molecular basis for epigenetic
regulation of gene expression. Therefore, studies of gametic
chromatin and its subsequent reorganization in the preim-
plantation embryo promise to shed light on processes such
as imprinting, reprogramming associated with somatic cell
nuclear transfer, and developmentally regulated gene
expression.
In developing and mature oocytes, the maternal genome
is packaged within nucleosomes that contain a high content
of the oocyte-specific histone variant H1FOO (H1oo)
(Tanaka et al., 2001). The maternal genome of mature
oocytes contains histones that lack appreciable levels of278 (2005) 367–380
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genome in MII oocytes contains histone H3 that is modified
by methylation at lysine 9 (Arney et al., 2002; Liu et al.,
2004). Thus, mature oocytes contain chromatin in a state
that is generally nonpermissive for transcription. The
paternal genome in sperm is packaged in a highly
condensed and transcriptionally inert configuration in which
the vast majority of histones have been replaced with
protamines, assembled upon DNA that is highly methylated
upon CpG dinucleotides.
In mice, male and female genomes undergo broad and
rapid chromatin reorganizations shortly after fertilization
leading to zygotic genome activation at the late 2 pronucleus
(2PN) stage of single-cell embryos (Ram and Schultz,
1993). The male pronucleus is rapidly stripped of prot-
amines, undergoes significant decondensation, and histones
of maternal origin (including H1FOO) are assembled upon
the paternal genome (Gao et al., 2004; Teranishi et al.,
2004). In addition, male pronuclear decondensation is
associated with active demethylation of CpG dinucleotides
of DNA to levels similar to that of the female pronucleus
(Mayer et al., 2000; Oswald et al., 2000). The maternal
genome behaves quite differently: The maternal genome is
arrested at metaphase II (MII) in mature oocytes. UponFig. 1. Localization of histone macroH2A during oocyte maturation. Confocal imag
the DNA (DNA-PI) combined with immunodetection with a-macroH2A antibody
late growth stage germinal vesicle stage (lg-GV). The arrow indicates an ex
representative oocyte at the fully grown GV stage (fg-GV). (C) A representativefertilization, chromosomes present at the oocyte metaphase
plate migrate to separate poles, and a haploid set of maternal
chromosomes are extruded as the second polar body. Prior
to synkaryogamy, male and female pronuclei individually
execute a single S-phase, merge, and rapidly complete the
first embryonic mitosis.
Subsequent stages of preimplantation development are
characterized by progressive, coordinated remodeling of
embryonic chromatin. In mice, histones become acetylated
at the late 2 pronuclei (2PN) stage (Kim et al., 2003), a
timing that is roughly coincident with zygotic genome
activation. Histone H1FOO is removed at the 2-cell stage
and the embryonic genome does not acquire somatic linker
histone H1 until the 4-cell stage (Gao et al., 2004). A second
wave of preimplantation embryonic gene activation occurs
as morulae develop to blastocysts (Hamatani et al., 2004).
The histone variant macroH2A is a core histone related to
canonical H2A that possesses a lengthy C-terminal nonhi-
stone domain (NHD) (Pehrson and Fried, 1992). A number
of studies suggest a general involvement of macroH2A in
heterochromatin: MacroH2A associates with the facultative
heterochromatin of inactive X chromosomes in female
somatic cells (Costanzi and Pehrson, 1998). However,
macroH2A1 is expressed at similar levels in male andes of individual maturing oocytes stained with propidium iodide to visualize
detected with FITC (macroH2A-FITC). (A) A representative oocyte at the
tranuclear, presumptive centrosomal concentration of macroH2A. (B) A
mature oocyte arrested at meiotic metaphase II (MII). Scale bar = 30 Am.
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function is not restricted to X chromosome inactivation.
Additional analyses show that macroH2A can inhibit
transcription because it can down-regulate NF-kappaB
transcription factor binding and impedes SWI/SNF chro-
matin remodeling (Angelov et al., 2003). MacroH2A may
also influence ADP-ribosylation of histones through a motif
present in the macroH2A NHD (Ladurner, 2003). Mac-
roH2A is widely expressed in blastocyst stage embryos,
which contain detectable macroH2A present upon X
chromosomes subject to imprinted inactivation in trophec-
todermal cells of female blastocysts (Costanzi et al., 2000).
Additional studies show that macroH2A often resides in
close proximity to pericentric heterochromatin (Costanzi et
al., 2000), often in juxtaposition to heterochromatin protein
1h (Hoyer-Fender et al., 2004; Turner et al., 2001), a marker
of pericentric heterochromatin.
MacroH2A has been analyzed extensively during murine
spermatogenesis. MacroH2A is expressed during the pachy-
tene stage of spermatogenesis, where it is associated with
sex vesicles containing sequestered X and Y chromosomes
(Hoyer-Fender et al., 2000, 2004; Richler et al., 2000), but
unlike somatic cells, this association does not require Xist
RNA (Turner et al., 2002). In addition, macroH2A has been
shown to associate with pericentric chromatin of all
chromosomes in pachytene oocytes (Hoyer-Fender et al.,
2004). Here we show that macroH2A is retained during the
remainder of oocyte maturation and is present in mature
oocytes. Upon fertilization, a transient asymmetry exists in
which macroH2A preferentially associates with the female
pronucleus. This maternal store of macroH2A is removed byTable 1
Developmental distribution of macroH2A
Group Developmental stagea


















a Abreviations: lg-GV: late growth stage germinal vesicle; fg-GV: fully grown ge
b Hours after hCG injection.
c At the 70-h time-point, some embryos had undergone asynchronous cell divisi
d Time after oocyte activation.
e At these time points, a progressive loss of signal to undetectable levels of macthe late 2 pronuclei stage and macroH2A protein of
embryonic origin does not appear until after the 8-cell
stage. This finding shows that embryos complete their first
three to four cell cycles in the absence of macroH2A, a
pattern quite different than that observed for linker H1
histones. Together, these results suggest that the coordinated
phases of embryonic genome activation are exquisitely
coordinated with extensive chromatin remodeling of the
early embryonic genome. These results show that dramatic
alterations in the content of histone variants occur in the
chromatin of developing preimplantation embryos.Materials and methods
Chemicals
Unless otherwise indicated, all chemicals were purchased
from Sigma (St. Louis, MO).
Animals and recovery of oocytes and embryos
CD-1 mice (Charles River Laboratories, Wilmington,
MA, USA) were used to obtain MII unfertilized oocytes,
sperm, and zygotes (12 h after mating). Female B6D2F1mice
(Charles River Laboratories) were used to obtain MII oocytes
for intracytoplasmic sperm injection (ICSI). Oocytes at the
germinal vesicle (GV) stage were retrieved from ovaries
harvested from CD-1 mice aged 8–12 weeks. Follicles within
ovaries were punctured with a sterile 25-gauge needle. After






N/A 13 13 (100)
N/A 22 22 (100)
N/A 17 17 (100)
22 hb 12 0 (0)
48 hb 18 0 (0)
60 hb 18 0 (0)
70 hb 14 0 (0)
70 hb 7 3 (42.8)
84 hb 22 22 (100)
104 hb 22 22 (100)
10 mind 9 9 (100)
1 hd 8 8 (100)
3 hd 16 16 (100)
4.5 hd,e 5 5 (100)
6 hd,e 15 15 (100)
12 hd,e 10 0 (0)
rminal vesicle; MII: metaphase II; 2PN: 2 pronuclei.
ons resulting in 9–12 nuclei.
roH2A after 12 h of parthenogenetic development was observed.l
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granulosa cells) were classified as late growth stage germinal
vesicle (lg-GV) oocytes. Oocytes larger than 75 Am
(associated with loosely attached granulosa cells) were
classified as fully grown germinal vesicle (fg-GVs) oocytes.
GOCs containing lg-GVoocytes were treated with 1.5 mg/ml
collagenase at 378C for 30 min, after which the granulosa
cells were stripped by repeated aspiration through a glass
pipette. Oocytes containing fg-GVs were stripped of gran-
ulosa cells by repeated aspiration of untreated GOCs through
a glass pipette, the tip diameter of which was slightly larger
than the diameter of an oocyte. The granulosa-denuded GVFig. 2. Distribution of macroH2A relative to chromatin markers in lg-GV and fg-G
to double immunofluorescence using antibodies against macroH2A (detected with
histone, detected with TRITC, red). Note that macroH2A protein is restricted to con
were subjected to immunofluorescence using the antibodies against macroH2A
(detected with FITC, green). Note the extensive colocalization of macroH2Awith H
coincide with centrosomes in lg-GV oocytes (see Fig. 3A).oocytes were then transferred into acidic Dulbecco’s PBS (pH
2.5) to remove zona pellucida.
Mature MII stage oocytes were collected from female
CD-1 mice subjected to the following hormone priming
protocol: Superovulation was induced with 10 IU of equine
chorionic gonadotrophin (eCG) followed 48 h later with 10
IU of human chorionic gonadotrophin (hCG). Oocytes were
freed of cumulus cells by brief exposure to 300 IU/ml of
hyaluronidase at 378C and gentle pipetting. Denuded MII
oocytes were either subjected to oocyte activation or
prepared for immunofluorescence by removing the zona
pellucida with acidic Dulbecco’s PBS (pH 2.5), followed byV stage oocytes. (A) Mouse lg-GV and fg-GV stage oocytes were subjected
FITC, green) and an antibody with general reactivity toward histones (pan-
densed chromatin in both stages. (B) Mouse lg-GVand fg-GV stage oocytes
(detected with TRITC, red) and the heterochromatin component HP1h
P1h. Arrows indicate extranuclear concentrations of macroH2A that likely
C.-C. Chang et al. / Developmental Biology 278 (2005) 367–380 371fixation in 4% paraformaldehyde in PBS for 15 min at room
temperature.
Female CD-1 mice, averaging 8 weeks of age, were
superovulated to provide embryos as described (Hogan et
al., 1994). After superovulation with 10 IU of eCG followed
by 10 IU of hCG 48 h later, females were paired with CD-1
males and inspected the following morning for copulation
plugs. Preimplantation embryos were flushed from oviducts
after the hCG treatment and incubated in KSOM + AA
medium (Specialty Media, Phillipsburg, NJ) before fixation.
Specifically, pronuclear stage embryos (2PN) were har-
vested and fixed at 22 h, 2-cell embryos at 48 h, 4-cell
embryos at 60 h, 8-cell and 9- to 12-cell embryos at 70 h,
morulae embryos at 84 h, and blastocyst embryos at 104 h,
after hCG injection.Fig. 3. Expression of macroH2A relative to centrosome (g-tubulin) and centrom
oocytes were subjected to double immunofluorescence with antibodies against ma
red). (B) Mouse lg-GV and fg-GVoocytes were subjected to double immunofluore
CREST antisera (detected with TRITC, red). Arrows indicate extranuclear, centroOocyte parthenogenetic activation
Mature MII oocytes were collected from CD-1 female
mice at 15 h after hCG treatment, then subjected to
parthenogenetic activation by exposure to activation
medium (calcium-free KSOM, 10 mM strontium chloride,
and 5 Ag/ml cytochalasin B) for 6 h. Oocytes were fixed
after 10 min, 1, 3, 4.5, 6, and 12 h after in activation
medium.
Intracytoplasmic sperm injection
Male CD-1 mice, 12 weeks of age, were used to obtain
sperm. The caudal epididymus was excised and then
punctured with a 25-gauge needle several times to releaseere (CREST) proteins in developing oocytes. (A) Mouse lg-GV and MII
croH2A (detected with FITC, green) and g-tubulin (detected with TRITC,
scence with antibodies against macroH2A (detected with FITC, green) and
somal concentrations of macroH2A.
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Fig. 5. Antibody penetration control. A representative 2-cell embryo is
shown that was stained with (A) DAPI to visualize DNA, (B) a-macroH2A
antibody detected with rhodamine Red-X, and (C) a mouse pan-histone
antibody detected with FITC. A three-color merge is shown in panel D.
These results indicate that chromatin can be readily detected in embryos
during developmental stages that lack macroH2A.
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Sperm were resuspended in TYH medium at a density of 5–
10 million/ml, then incubated at 378C, 5% CO2, for 45 min
prior to ICSI. The sperm suspension was then mixed with an
equal volume of 12% (w/v) polyvinyl pyrolidone (PVP; Mr
360  103) dissolved in saline (0.9% NaCl). Mature MII
oocytes were collected from B6D2F1 female mice at 14 h
after hCG treatment and transferred into M2 medium before
injection. Holding pipettes with 80 Am outside and 15 Am
inside diameters were created using a pipette puller (P-87;
Sutter Instrument Co., Novato, CA). Injection pipettes (6–8
Am inside diameter) were loaded with mercury and attached
to a piezo-driving unit (PMAS-CT150, Prime Tech, Japan).
Each sperm head was cut off using piezo pulses in
conjunction with the injection pipette. Sperm heads were
then washed and injected into the oocytes after piezo
drilling through the zona and oolemma. The procedure of
micromanipulation was essentially as described (Kimura
and Yanagimachi, 1995), except that it was done at room
temperature (20–248C). After ICSI, injected oocytes were
fixed after 15 min, 1, 3, 5, and 7 h of KSOM + AA medium
incubation at 378C, 5% CO2.
Immunofluorescence and laser-scanning confocal
microscopy
The rabbit anti-macroH2A antibody used in this study
was created by inoculating a rabbit with the recombinant
nonhistone domain (NHD) obtained by expression of an
NHD fragment of a macroH2A1.2 cDNA fused to a GST
expression vector. Precise details concerning the creation of
this antibody are presented in a separate manuscript (Ma et
al., submitted for publication). This antibody recognizes a
single 42-kDa band (macroH2A) on Western blots of mouse
protein and identifies inactive X chromosomes in female
somatic cells (Akbarian et al., 2001; Ganesan et al., 2002;
Wutz et al., 2002).
Oocytes and embryos were prepared for immunofluor-
escence by fixation in a 4% paraformaldehyde solution at
room temperature for 15 min. They were then washed in
phosphate-buffered saline (PBS) with 0.2% Tween 20 three
times, and left in blocking buffer (PBS/0.2% Tween 20 and
10 mg/ml BSA) for 30 min at 378C. Oocytes and embryos
were then double stained to visualize macroH2A and DNA.
Briefly, samples were incubated in rabbit anti-histone
macroH2A antibody (Ma et al., submitted for publication)
diluted 1:1000 for 30 min at 378C. Embryos were then
washed in PBS/0.2% Tween 20 three times and incubated in
fluorescein isothiocyanate (FITC)-conjugated donkey anti-
rabbit IgG (cat. no. 711-095-152, Jackson ImmunoResearch
Inc., West Grove, PA) (1:200) for 1 h at 378C. Finally,Fig. 4. Distribution of macroH2A during mouse preimplantation embryonic develo
to visualize the DNA (DNA-PI) combined with immunodetection with a-macro
zygote with 2 pronuclei. (B) Representative 2-cell embryo (arrows in rows A and
(D) 8-cell embryo. (E) Representative morula. (F) Representative blastocyst.oocytes or embryos were washed three times in PBS/0.2%
Tween 20, stained for DNA with 2.5 Ag/ml propidium
iodide, and mounted in PBS containing 50% glycerol and
25 mg/ml NaN3. Oocytes and embryos were analyzed with a
laser-scanning confocal microscope (Leica TCS SP2,
Mannheim, Germany). Individual confocal sections were
electronically merged so that all nuclei were visible in a
single image. For antibody penetration controls (Fig. 5),
embryos were processed as above and doubly stained for
macroH2A (detected with goat anti-rabbit IgG conjugated to
rhodamine Red-X (cat. no. 111-295-144, Jackson Immu-
noResearch Inc.) (1:200) for 1 h at 378C. and a mouse
monoclonal pan-histone antibody (Chemicon, cat. no.
MAB052) (1:100) [detected with goat anti-mouse IgG
conjugated to FITC (cat. no. 115-095-160), Jackson
ImmunoResearch Inc.] (1:200) for 1 h at 378C.
Reagents used for additional immunofluorescence analy-
ses follow. Double antibody staining was performed with a
pan-histone antibody (Chemicon, cat. no. MAB052 diluted
1:100) and goat polyclonal HP1h (Abcam, cat. no. 11164,
diluted 1:50). In addition, anti-g-tubulin (Sigma, cat. no. T-
6557, diluted 1:50), and human anti-centromere proteins
(CREST) (Antibodies Incorporated, cat. no. 15-235, diluted
1:40), were used in combination with anti-macroH2A
(1:1000). Rabbit primary antibodies were detected with
FITC- or TRITC-conjugated anti-rabbit IgG (cat. no. 711-pment. Staged preimplantation embryos were stained with propidium iodide
H2A antibody detected with FITC (MacroH2A-FITC). (A) Representative
B indicate macroH2A content in residual polar bodies). (C) 4-cell embryo.
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search Laboratories, 1:200). Mouse pan-histone or g-tubulin
antibodies were detected with donkey anti-mouse TRITC-
conjugated IgG (cat. no. 715-025-150, Jackson ImmunoR-
esearch Inc., 1:200). The HP1h antibodies were detected
with donkey anti-goat FITC-conjugated IgG (cat. no. 705-
095-003, Jackson ImmunoResearch Inc., 1:200), and CREST
antibodies were detected with goat anti-human TRITC-
conjugated IgG (cat. no. 109-025-003, Jackson Immuno-
Research Inc., 1:200). As before, oocytes were mounted in
PBS containing 50% glycerol and 25 mg/ml NaN3 as an
antifading reagent and analyzed with a laser-scanning
confocalmicroscope (Leica TCS SP2,Mannheim,Germany).Results
MacroH2A distribution in developing and mature oocytes
We investigated the distribution of macroH2A during the
course of the mouse oocyte maturation process. To do this,
we collected granulosa oocyte complexes (GOCs) from
ovaries and assessed oocytes stages. Oocytes containing
germinal vesicles at the late growth (lg-GV) stage were
surrounded by compact masses of granulosa cells and had
oocyte diameters of less than 70 Am. Oocytes containing
fully grown germinal vesicles (fg-GV) had diameters greater
than 75 Am and loosely attached granulosa cells. Both lg-
GV and fg-GV oocytes contained macroH2A signal that
colocalized with condensed chromatin (Figs. 1A and B).
However, macroH2A exhibited more intense deposition in
lg-GV oocytes, where it was highly concentrated in several
discrete spots (Fig. 1A). Of 35 GV stage oocytes, all had
readily detectable macroH2A present in the nucleus (Table
1). A portion of the total macroH2A pool was present in an
extranuclear position likely coincident with centrosomes, a
localization pattern for macroH2A previously observed in
embryonic stem cells and certain somatic cells (Chadwick
and Willard, 2002; Mermoud et al., 2001; Rasmussen et al.,
2000). In mature MII oocytes, macroH2A still associated
with chromosomes, which had aligned on the metaphase II
plate (Fig. 1C). Of 17 MII stage oocytes, all had macroH2A
present upon chromosomes aligned at the metaphase plate
(Table 1).
We performed double immunofluorescence experiments
to more fully investigate the distribution of macroH2A
relative to oocyte chromatin. Analysis of macroH2A
distribution as compared to total chromatin (using a pan-
histone antibody) revealed that macroH2A was spatially
restricted to highly condensed subregions of chromatin in
lg-GV and fg-GV oocytes (Fig. 2A). Because this patternFig. 6. Localization of macroH2A in parthenogenetic activated oocytes. Unfertiliz
at 10 min, 1, 3, 4.5, 6, and 12 h after activation. Activated oocytes were stained w
by immunofluorescence (macroH2A-FITC). MacroH2Awas associated with DNA
though the signal is successively lost during the decondensation process prior towas reminiscent of pericentric heterochromatin, we cos-
tained for macroH2A and heterochromatin protein 1-h
(HP1h), a known component of pericentric heterochromatin
(Fig. 2B) (Furuta et al., 1997; Motzkus et al., 1999;
Wreggett et al., 1994). We observed a high degree of
colocalization between macroH2A and HP1h (Fig. 2B).
We next sought to investigate the small extranuclear
concentrations of macroH2A in developing oocytes. We
observed that extranuclear macroH2A colocalizes with g-
tubulin (a centrosomal marker) in lg-GV oocytes (Fig. 3A).
In addition, we found that some macroH2A and g-tubulin
was concentrated as spindle poles in MII oocytes (Fig. 3B).
Though similar in size, punctate concentrations of mac-
roH2A within the nuclear volume colocalized with inter-
phase centromere proteins visualized with CREST antisera
(human scleroderma autoimmune serum that detects cen-
tromeric kinetochore proteins).
Together, these results indicate that a maternal store of
macroH2A exists in developing and mature oocytes, where
the majority of macroH2A resides in pericentric hetero-
chromatin (as judged by its proximity to HP1h and
kinetochore proteins). In addition, a small pool of mac-
roH2A associates with centrosomes, a localization pattern
previously described in other cells (Chadwick and Willard,
2002; Mermoud et al., 2001; Rasmussen et al., 2000).
MacroH2A in preimplantation embryos
Because a maternal store of macroH2A resides at the
metaphase plate in mature oocytes, we investigated the fate of
this store in preimplantation embryos. We examined zygotes,
2-, 4-, 8-, and 9- to 12-cell embryos, morula, and blastocysts
for the distribution of macroH2A protein. Surprisingly, we
found that macroH2A was undetectable in normal embryos
by the late 2 pronuclei (late 2PN) stage (Fig. 4A). We also
found that macroH2Awas undetectable in the cells of 2-, 4-,
and 8-cell embryos (Figs. 4B–D; Table 1). Though nuclear
macroH2A was apparently absent in these early cleavage
stage embryos, we often observed macroH2A protein in
residual polar bodies (Fig. 4B), which served as internal
controls for the detection of macroH2A by immunofluor-
escence. All embryos at morula and blastocyst stages
contained nuclear macroH2A in blastomere nuclei (Figs.
4E and F; Table 1). After the appearance of macroH2A of
embryonic origin, the intensity of nuclear macroH2A
immunostaining gradually increased until embryos reached
the blastocyst stage (Fig. 4F), wheremacroH2Awas observed
in all nuclei of the inner cell mass and trophectoderm, a result
consistent with a previous report (Costanzi et al., 2000).
Because early preimplantation embryos contain relatively
large volumes of cytoplasm and nucleoplasm, we performeded MII oocytes were activated with strontium and fixed for immunostaining
ith propidium iodide to detect DNA (DNA-PI) and macroH2Awas detected
on the initial meiotic metaphase plate and during pronuclear decondensation
synkaryogamy.
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penetrate to chromatin.We subjected early embryos to double
immunofluorescence designed to simultaneously detect
macroH2A and histones using a monoclonal pan-histone
antibody that recognizes the histone fold motif (Chemicon,Fig. 7. Localization of macroH2A in ICSI embryos. Unfertilized MII oocytes were
1, 3, 5, and 7 h after injection. Embryos derived by ICSI were stained with pro
immunofluorescence (macroH2A-FITC). MacroH2A was associated with matern
progressively lost from the decondensing female pronuclei (m). In contrast,
decondensation process. This maternal/paternal asymmetry persisted until macroHcat. no. MAB052). We found that bulk histones but not
macroH2A could be readily identified in early preimplanta-
tion embryos (Fig. 5). We conclude that macroH2A is rapidly
lost from embryos by the late 2PN stage and that nuclear
macroH2A of embryonic origin does not appear until after theinjected with single sperm heads, then fixed for immunostaining at 15 min,
pidium iodide to detect DNA (DNA-PI) and macroH2A was detected by
al chromosomes initially present at the meiotic metaphase plate but was
macroH2A was undetectable on paternal pronuclei (p) throughout the
2A became undetectable at 7 h post-ICSI.
Table 2















15 min 6 0 (0) 6 (100)
1 h 5 0 (0) 5 (100)
3 h 6 0 (0) 6 (100)
5 h 4 0 (0) 4 (100)
7 h 5 0 (0) 0 (0)
C.-C. Chang et al. / Developmental Biology 278 (2005) 367–380 3778-cell stage. Hence, cleavage stage embryos execute their
first three to four mitotic divisions in the absence of
detectable macroH2A protein.
At the 70 h time point, we observed mostly 8-cell
embryos, all of which lacked detectable macroH2A in
blastomeres (Table 1). However, a few 70-h embryos had
undergone subsequent asynchronous cell divisions resulting
in embryos with 9–12 cells (b9–12 cellQ embryos; Table 1).
We observed the earliest appearance of macroH2A of
embryonic origin in these post-8-cell embryos. Four post-8-
cell embryos exhibited extranuclear accumulations of mac-
roH2A near the cytoplasmic membrane, possibly represent-
ing newly synthesized macroH2A, while three 9- to 12-cell
embryos had barely detectable macroH2A present in the
nucleus (Table 1). We conclude that the onset of embryonic
macroH2A expression commences immediately following
the 8-cell stage.
MacroH2A in parthenogenetic embryos
We investigated the behavior of macroH2A in partheno-
genetically activated oocytes to more closely follow the loss
of macroH2A from pronuclei. Mature MII oocytes were
collected from mouse oviducts and activated to undergo cell
division through the use of strontium and cytochalasin B.
Activated oocytes were fixed for immunofluorescence after
10 min, 1, 3, 4.5, 6, and 12 h (Fig. 6). After 10 min of
activation, chromosomes (containing maternal macroH2A)
still resided on the metaphase plate. After 1 h, we observed
an anaphase configuration of chromosomes, which still
possessed macroH2A. By 3 h, condensed pronuclei had
formed, which still contained abundant macroH2A. Pronu-
clei underwent a progressive decondensation at 4.5 and 6 h
time points, associated with increasingly diffuse macroH2A
immunostaining. After 12 h of development, parthenoge-
netic embryos lacked detectable macroH2A.
MacroH2A associates exclusively with maternal pronuclei
prior synkaryogamy
The previous parthenogenesis results confirmed that
macroH2A is gradually lost from female pronuclei after
oocyte activation. To more precisely investigate the behav-
ior of macroH2A in normal embryos created by fertilization,
we performed intracytoplasmic sperm injection (ICSI) to
generate temporally synchronized cohorts of embryos.
Following injection of sperm heads into mature MII
oocytes, zygotes were fixed for immunofluorescence after
15 min, 1, 3, 5, and 7 h (Fig. 7; Table 2). At 15 min post-
ICSI, maternal chromosomes (containing macroH2A) still
resided on metaphase plates, while injected sperm heads
were condensed and devoid of detectable macroH2A. After
1 h, paternal genome decondensation was well under way,
but paternal pronuclei lacked detectable macroH2A. In
contrast, the maternal chromosomes were entering meiotic
anaphase after 1 h, with abundant macroH2A still presentupon maternal chromosomes. By 3 h, decondensed paternal
pronuclei were extensively decondensed and devoid of
detectable macroH2A, while maternal macroH2A was
distributed between decondensed female pronuclei and
polar bodies. This asymmetry in macroH2A localization
persisted into the 5-h time point, but by 7 h macroH2A
became undetectable.Discussion
These results describe for the first time the kinetics of
macroH2A expression and localization during the complete
course of oocyte maturation and preimplantation develop-
ment. The results indicate that the expression and locali-
zation of macroH2A are carefully orchestrated and that a
maternal store of macroH2A is rapidly removed after
fertilization, a process that is complete by the late 2PN
stage. Embryos then execute three cell cycles with
undetectable levels of macroH2A prior to the appearance
of macroH2A of embryonic origin.
Mature oocytes are transcriptionally inactive and con-
tain abundant macroH2A present at the metaphase plate. In
late 2PN embryos, we find macroH2A only within residual
polar bodies, which likely represents macroH2A of
maternal origin that is extruded with polar bodies. We
followed the loss of macroH2A from female pronuclei by
activating oocytes to undergo parthenogenetic develop-
ment. We found that parthenogenetic pronuclei progres-
sively lose macroH2A as they decondense, but we cannot
at present determine if loss of macroH2A is an active
process or a passive event caused by a failure to
reassemble macroH2A chromatin during the first embry-
onic S-phase. Our experiments with ICSI revealed that a
maternal–paternal asymmetry exists during the initial hours
after fertilization in which macroH2A is preferentially
associated with female pronuclei. This sequence is similar
to that described for methylation of lysine 9 of histone H3,
which also shows a transient maternal preference shortly
after fertilization (Liu et al., 2004). These issues aside, it is
clear that late 2PN embryos derived by normal fertiliza-
tion, parthenogenesis, or ICSI lack appreciable amounts of
macroH2A.
C.-C. Chang et al. / Developmental Biology 278 (2005) 367–380378Previous studies involving macroH2A proteins have
been complicated by the existence of at least three related
macroH2A protein isoforms. In mice, the gene encoding
macroH2A1 yields two alternatively spliced transcripts
resulting in two protein isoforms of similar molecular
weight, macroH2A1.1 and macroH2A1.2 (Pehrson et al.,
1997; Rasmussen et al., 1999). The antibody used in this
study (Ma et al., submitted for publication) was generated
by inoculating rabbits with a recombinant protein corre-
sponding to the entire nonhistone domain of macroH2A1.2.
Therefore, this antibody does not likely distinguish between
macroH2A1.1/1.2 protein isoforms. Additional studies will
be required to assess subtle differences (if any) in the
distribution of specific macroH2A protein isoforms in
oocytes and preimplantation embryos. A second gene
encodes a related protein, macroH2A2, that differs sub-
stantially from the macroH2A1.1/1.2 isoforms (Chadwick
and Willard, 2001; Costanzi and Pehrson, 2001). Analyses
of human cells that express both macroH2A1 and mac-
roH2A2 proteins revealed that similar but not identical
subnuclear localization patterns exist for these proteins
(Costanzi and Pehrson, 2001), and that macroH2A2, like
macroH2A1, can colocalize with inactive X chromosomes
(Chadwick and Willard, 2001). Additional studies will be
needed to determine if macroH2A2 is expressed in oocytes
and preimplantation embryos.
Previous studies found macroH2A present at centro-
somes in embryonic stem cells and a variety of somatic cellsFig. 8. Kinetics of chromatin assembly in maturing mouse oocytes and preimplan
permissive acetylation modifications (green bars) on histone H3 at lysines K9 and
oocytes but reappear in 1-cell embryos prior to the onset of zygotic genome acti
variants implicated in gene silencing (red bars) exhibit delayed kinetics. Maternal
replaced by somatic H1 linker histones. The transcriptionally repressive methyl-H
shown, which are reminiscent of the H1FOO-somatic H1 histone transition. Note
after zygotic genome activation. References: a: Kim et al. (2003); b: Ram and Sch
(2004); f: Arney et al. (2002); g: Liu et al. (2004); h: this study.(Mermoud et al., 2001; Rasmussen et al., 2000). This
centrosomal pool of macroH2A may represent material
targeted for proteasome-dependent degradation, a mecha-
nism common to a variety of other chromatin proteins
(Chadwick and Willard, 2002). Further studies will be
required to determine if 2PN embryos utilize this process for
the degradation of macroH2A.
Chromatin is exquisitely and dynamically regulated in
oocytes and early embryos as judged by a compilation of
results from several studies. By comparing the kinetics of
appearance and disappearance of chromatin markers for
transcriptional activity and silence an interesting picture
emerges (Fig. 8) in which broad reorganizations of
chromatin are tightly orchestrated with the transcriptional
status of the developing oocyte and embryonic genome.
Acetylation events involving lysines 9 and 14 of histone H3
and lysines 5, 8, 12, and 16 of histone H4, have been
carefully analyzed in maturing oocytes and preimplantation
embryos. In all cases, acetylation was abundant in GV
oocytes but severely reduced, if not absent, in transcrip-
tionally quiescent MII oocytes (Kim et al., 2003). The
mouse zygotic genome first becomes transcriptionally active
in late 2PN embryos after the first zygotic S-phase (Ram
and Schultz, 1993). Recent findings show that zygotic
genome activation (ZGA) at the 2PN corresponds to the first
of two waves of genome activation in preimplantation
embryos (Hamatani et al., 2004). This initial wave of ZGA
occurs as histones H3 and H4 become reacetylated (Kim ettation embryos. Analysis of scientific literature reveals that transcriptionally
K14, and histone H4 at lysines K5, K8, K12, and K16, are absent in MII
vation at the late 2PN stage (blue bar). Histone modifications and histone
linker histone H1FOO is removed from late 2PN (1-cell) embryos and later
3-K9 modification exhibits similar kinetics. Finally, macroH2A kinetics are
that repressive chromatin is assembled later than permissive chromatin and
ultz (1993); c: Tanaka et al. (2001); d: Gao et al. (2004); e: Teranishi et al.
C.-C. Chang et al. / Developmental Biology 278 (2005) 367–380 379al., 2003). These findings agree with a previous study using
antibodies to acetyl H4-K5 and a pan-acetylated histone
antibody (Adenot et al., 1997). A subsequent (and more
substantial) wave of embryonic genome transcription occurs
just prior to compaction and morula formation (Hamatani et
al., 2004).
In contrast, the establishment of repressive chromatin
occurs well after ZGA and relies heavily upon replacement
events involving histone variants. During ovarian develop-
ment, somatic linker H1 histones are progressively lost from
developing oocytes (Clarke et al., 1997). The oocyte-
specific linker histone H1FOO (H1oo) (Tanaka et al.,
2001) becomes present in the chromatin of GV and MII
oocytes and is rapidly incorporated into male pronuclei
shortly after fertilization (Gao et al., 2004). However,
embryos lack significant levels of H1 histones at the 2-cell
stage (Tanaka et al., 2001) prior to replacement with somatic
H1s in the nuclei of 4-cell and later embryos (Gao et al.,
2004; Teranishi et al., 2004). An oocyte-specific form of
linker histone, H1FOO, is removed by the late 2PN stage
but replaced with somatic H1s at the 4-cell stage (Gao et al.,
2004). Our results show that macroH2A is not acquired in
embryonic chromatin until after the 8-cell stage. Thus, early
embryos do not acquire macroH2A until 1–2 cell divisions
after the somatic H1 transition (Fig. 8). Histone H3
dimethylated at lysine 9 (me-H3-K9) is present in GV and
mature oocytes but is absent from sperm and the male
genome until the 4-cell stage. The me-H3-K9 modification
persists on the maternal genome in both late 2PN and 2-cell
embryos (Liu et al., 2004). The asymmetry of me-H3-K9
with regards to male and female pronuclei is associated with
the preferential recruitment of the heterochromatin compo-
nent HP1h to the maternal genome in the period immedi-
ately following fertilization (Arney et al., 2002). In similar
fashion, we find that macroH2A preferentially associates
with the maternal pronucleus in zygotes, prior to its loss
before synkaryogamy. Thus, a striking asymmetry exists in
zygote chromatin because maternal pronuclei retain patterns
of histone methylation and macroH2A content that are
undetectable in male pronuclei. This situation may have
implications for epigenetic regulation of imprinting. HP1h
(Arney et al., 2002) is recruited to the paternal genome in
late 2PN embryos, prior to the onset of paternal H3-K9
methylation, a surprising result since methylation of H3-K9
can serve as a cis-acting binding site for HP1s (Lachner et
al., 2001; Maison et al., 2002; Rea et al., 2000). In contrast,
HP1g is uniformly recruited to both male and female
pronuclei at the late 2PN stage (Arney et al., 2002).
The regulation of gene expression during the remainder
of development involves numerous lineage-specific gene-
silencing events involving macroH2A and many other
heterochromatin proteins. We find it interesting macroH2A
of embryonic origin is not associated with the embryonic
genome until well after acetylation of genomic core histones
H3 and H4 has occurred at the 2PN stage (Kim et al., 2003).
Indeed, embryonic macroH2A is not present until after bothwaves of embryonic genome activation have been initiated
(Hamatani et al., 2004). Taken together, these results
suggest a possible sequence of gene regulation in which
the zygotic genome is first widely activated, perhaps in an
unregulated fashion. Subsequent gene-silencing events may
represent the first instance of regulated gene expression in
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